Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BG 75202

Next Previous
Drug Profile

BG 75202

Alternative Names: BG-75202

Latest Information Update: 10 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BeOne Medicines
  • Class Antineoplastics; Small molecules
  • Mechanism of Action KAT6A protein inhibitors; KAT6B protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Breast cancer; Solid tumours

Most Recent Events

  • 29 Oct 2025 Preclinical trials in Breast cancer in USA (PO), prior to October 2025 (BeOne Medicines website, November 2025)
  • 29 Oct 2025 Preclinical trials in Solid tumours in USA (PO), prior to October 2025 (BeOne Medicines website, November 2025)
  • 29 Oct 2025 BeOne Medicines plans a phase Ia/Ib trial for Breast cancer and other Solid tumours (Late-stage disease, Monotherapy, Combination therapy, Metastatic disease, Second-line therapy or greater) in USA (PO), in December 2025 (EudraCT2025-523553-34-00) (NCT07222267)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top